Anne Rossel
How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study
Rossel A, Zandberg K, Albrich W, Huttner A. How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study. Clin Microbiol Infect 2021; 28:297.e1-297.e6.
Jun 8, 2021How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study
Jun 8, 2021Clin Microbiol Infect 2021; 28:297.e1-297.e6
Rossel Anne, Zandberg Kimberly P M, Albrich Werner, Huttner Angela
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
von Dach E, Bochud P, Kaiser L, Harbarth S, Rossel A, McCallin S, Lemmenmeier E, Kohler P, Huttner B, Gayet-Ageron A, Flury D, Cuvelier C, Prendki V, Brunel A, Albrich W, Huttner A. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA 2020; 323:2160-2169.
Jun 2, 2020Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
Jun 2, 2020JAMA 2020; 323:2160-2169
von Dach Elodie, Bochud Pierre-Yves, Kaiser Laurent, Harbarth Stephan, Rossel Anne, McCallin Shawna, Lemmenmeier Eva, Kohler Philipp, Huttner Benedikt, Gayet-Ageron Angèle, Flury Domenica, Cuvelier Clémence, Prendki Virginie, Brunel Anne-Sophie, Albrich Werner, Huttner Angela
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
Huttner A, Albrich W, Bochud P, Gayet-Ageron A, Rossel A, Dach E, Harbarth S, Kaiser L. PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia. BMJ Open 2017; 7:e017996.
Jul 13, 2017PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
Jul 13, 2017BMJ Open 2017; 7:e017996
Huttner Angela, Albrich Werner, Bochud Pierre-Yves, Gayet-Ageron Angèle, Rossel Anne, Dach Elodie von, Harbarth Stephan, Kaiser Laurent